documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
32 rows where docket_id = "FDA-2023-N-0002" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, last_modified, posted_date (date), comment_start_date (date), last_modified (date)
document_type 2
agency_id 1
- FDA 32
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2023-N-0002-0032 | FDA | None FDA-2023-N-0002 | New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications, Change of Sponsor, Change of Sponsor Address | Rule | Final Rule | 2024-02-27T05:00:00Z | 2024 | 2 | 2024-02-27T05:00:00Z | 2024-02-27T14:10:51Z | 2024-03765 | 0 | 0 | 0900006486432bd9 | |
| FDA-2023-N-0002-0031 | FDA | None FDA-2023-N-0002 | New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor Address | Rule | Final Rule | 2023-12-06T05:00:00Z | 2023 | 12 | 2023-12-06T05:00:00Z | 2024-05-06T12:04:48Z | 2023-26545 | 0 | 0 | 09000064862ff365 | |
| FDA-2023-N-0002-0029 | FDA | None FDA-2023-N-0002 | FOI Summary sN 038-439, approved April 10, 2023 | Supporting & Related Material | Background Material | 2023-08-16T04:00:00Z | 2023 | 8 | 2023-08-16T17:21:47Z | 0 | 0 | 0900006485e365b3 | |||
| FDA-2023-N-0002-0026 | FDA | None FDA-2023-N-0002 | FOI Summary oN 141-562, approved May 5, 2023 | Supporting & Related Material | Background Material | 2023-08-16T04:00:00Z | 2023 | 8 | 2023-08-16T17:21:45Z | 0 | 0 | 0900006485e365b0 | |||
| FDA-2023-N-0002-0028 | FDA | None FDA-2023-N-0002 | FOI Summary oN 141-571, approved May 1, 2023 | Supporting & Related Material | Background Material | 2023-08-16T04:00:00Z | 2023 | 8 | 2023-08-16T17:21:46Z | 0 | 0 | 0900006485e365b2 | |||
| FDA-2023-N-0002-0023 | FDA | None FDA-2023-N-0002 | FOI Summary oA 200-750, approved May 25, 2023 | Supporting & Related Material | Background Material | 2023-08-16T04:00:00Z | 2023 | 8 | 2023-08-16T17:21:43Z | 0 | 0 | 0900006485e365ad | |||
| FDA-2023-N-0002-0020 | FDA | None FDA-2023-N-0002 | New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications, Change of Sponsor, Change of Sponsor Address | Rule | Final Rule | 2023-08-16T04:00:00Z | 2023 | 8 | 2023-08-16T04:00:00Z | 2023-08-16T13:52:41Z | 2023-17454 | 0 | 0 | 0900006485e5693b | |
| FDA-2023-N-0002-0025 | FDA | None FDA-2023-N-0002 | FOI Summary oN 141-555, approved June 9, 2023 | Supporting & Related Material | Background Material | 2023-08-16T04:00:00Z | 2023 | 8 | 2023-08-16T17:21:44Z | 0 | 0 | 0900006485e365af | |||
| FDA-2023-N-0002-0030 | FDA | None FDA-2023-N-0002 | FOI Summary sN 141-406, Approved June 21, 2023 | Supporting & Related Material | Background Material | 2023-08-16T04:00:00Z | 2023 | 8 | 2023-08-16T17:21:48Z | 0 | 0 | 0900006485e365b4 | |||
| FDA-2023-N-0002-0021 | FDA | None FDA-2023-N-0002 | FOI Summary oA 200-612, approved April 5, 2023 | Supporting & Related Material | Background Material | 2023-08-16T04:00:00Z | 2023 | 8 | 2023-08-16T17:21:41Z | 0 | 0 | 0900006485e365ab | |||
| FDA-2023-N-0002-0022 | FDA | None FDA-2023-N-0002 | FOI Summary oA 200-748, approved May 10, 2023 | Supporting & Related Material | Background Material | 2023-08-16T04:00:00Z | 2023 | 8 | 2023-08-16T17:21:42Z | 0 | 0 | 0900006485e365ac | |||
| FDA-2023-N-0002-0024 | FDA | None FDA-2023-N-0002 | FOI Summary oA 200-751, approved June 22, 2023 | Supporting & Related Material | Background Material | 2023-08-16T04:00:00Z | 2023 | 8 | 2023-08-16T17:21:43Z | 0 | 0 | 0900006485e365ae | |||
| FDA-2023-N-0002-0027 | FDA | None FDA-2023-N-0002 | FOI Summary oN 141-570, appproved April 20, 2023 | Supporting & Related Material | Background Material | 2023-08-16T04:00:00Z | 2023 | 8 | 2023-08-16T17:21:45Z | 0 | 0 | 0900006485e365b1 | |||
| FDA-2023-N-0002-0008 | FDA | None FDA-2023-N-0002 | FOI Summary oA 200-737 - Approved February 2, 2023 | Supporting & Related Material | Background Material | 2023-05-03T04:00:00Z | 2023 | 5 | 2023-05-04T20:07:03Z | 0 | 0 | 09000064859c26c6 | |||
| FDA-2023-N-0002-0018 | FDA | None FDA-2023-N-0002 | FOI Summary sA 200-721 - Approved January 12, 2023 | Supporting & Related Material | Background Material | 2023-05-03T04:00:00Z | 2023 | 5 | 2023-05-04T20:10:20Z | 0 | 0 | 09000064859c26cd | |||
| FDA-2023-N-0002-0007 | FDA | None FDA-2023-N-0002 | FOI Summary oA 200-736 - Approved January 13, 2023 | Supporting & Related Material | Background Material | 2023-05-03T04:00:00Z | 2023 | 5 | 2023-05-04T20:06:49Z | 0 | 0 | 09000064859c26c5 | |||
| FDA-2023-N-0002-0017 | FDA | None FDA-2023-N-0002 | FOI Summary sA 200-701 - Approved February 9, 2023 | Supporting & Related Material | Background Material | 2023-05-03T04:00:00Z | 2023 | 5 | 2023-05-04T20:09:48Z | 0 | 0 | 09000064859c26cc | |||
| FDA-2023-N-0002-0019 | FDA | None FDA-2023-N-0002 | FOI Summary sN 141-426 - Approved January 12, 2023 | Supporting & Related Material | Background Material | 2023-05-03T04:00:00Z | 2023 | 5 | 2023-05-04T20:10:47Z | 0 | 0 | 09000064859c28ad | |||
| FDA-2023-N-0002-0015 | FDA | None FDA-2023-N-0002 | FOI Summary oA 200-746 - Approved March 30, 2023 | Supporting & Related Material | Background Material | 2023-05-03T04:00:00Z | 2023 | 5 | 2023-05-04T20:09:16Z | 0 | 0 | 09000064859c27f9 | |||
| FDA-2023-N-0002-0003 | FDA | None FDA-2023-N-0002 | FOI Summary oA 200-732 - Approved January 5, 2023 | Supporting & Related Material | Background Material | 2023-05-03T04:00:00Z | 2023 | 5 | 2023-05-04T19:54:47Z | 0 | 0 | 09000064859c2628 | |||
| FDA-2023-N-0002-0016 | FDA | None FDA-2023-N-0002 | FOI Summary oA 200-747 - Approved March 31, 2023 | Supporting & Related Material | Background Material | 2023-05-03T04:00:00Z | 2023 | 5 | 2023-05-04T20:09:29Z | 0 | 0 | 09000064859c26cb | |||
| FDA-2023-N-0002-0013 | FDA | None FDA-2023-N-0002 | FOI Summary oA 200-744 - Approved March 29, 2023 | Supporting & Related Material | Background Material | 2023-05-03T04:00:00Z | 2023 | 5 | 2023-05-04T20:08:48Z | 0 | 0 | 09000064859c26ca | |||
| FDA-2023-N-0002-0011 | FDA | None FDA-2023-N-0002 | FOI Summary oA 200-741 - Approved February 24, 2023 | Supporting & Related Material | Background Material | 2023-05-03T04:00:00Z | 2023 | 5 | 2023-05-04T20:08:18Z | 0 | 0 | 09000064859c26c9 | |||
| FDA-2023-N-0002-0006 | FDA | None FDA-2023-N-0002 | FOI Summary oA 200-735 - Approved January 13, 2023 | Supporting & Related Material | Background Material | 2023-05-03T04:00:00Z | 2023 | 5 | 2023-05-04T20:06:28Z | 0 | 0 | 09000064859c26c4 | |||
| FDA-2023-N-0002-0012 | FDA | None FDA-2023-N-0002 | FOI Summary oA 200-743 - Approved March 21, 2023 | Supporting & Related Material | Background Material | 2023-05-03T04:00:00Z | 2023 | 5 | 2023-05-04T20:08:32Z | 0 | 0 | 09000064859c26a5 | |||
| FDA-2023-N-0002-0005 | FDA | None FDA-2023-N-0002 | FOI Summary oA 200-734 - Approved January 12, 2023 | Supporting & Related Material | Background Material | 2023-05-03T04:00:00Z | 2023 | 5 | 2023-05-04T19:56:13Z | 0 | 0 | 09000064859c265d | |||
| FDA-2023-N-0002-0004 | FDA | None FDA-2023-N-0002 | FOI Summary oA 200-733 - Approved January 12, 2023 | Supporting & Related Material | Background Material | 2023-05-03T04:00:00Z | 2023 | 5 | 2023-05-04T19:55:04Z | 0 | 0 | 09000064859c269f | |||
| FDA-2023-N-0002-0014 | FDA | None FDA-2023-N-0002 | FOI Summary oA 200-745 - Approved March 21, 2023 | Supporting & Related Material | Background Material | 2023-05-03T04:00:00Z | 2023 | 5 | 2023-05-04T20:09:02Z | 0 | 0 | 09000064859c27f8 | |||
| FDA-2023-N-0002-0009 | FDA | None FDA-2023-N-0002 | FOI Summary oA 200-738 - Approved January 11, 2023 | Supporting & Related Material | Background Material | 2023-05-03T04:00:00Z | 2023 | 5 | 2023-05-04T20:07:23Z | 0 | 0 | 09000064859c26c7 | |||
| FDA-2023-N-0002-0010 | FDA | None FDA-2023-N-0002 | FOI Summary oA 200-739 - Approved February 2, 2023 | Supporting & Related Material | Background Material | 2023-05-03T04:00:00Z | 2023 | 5 | 2023-05-04T20:08:04Z | 0 | 0 | 09000064859c26c8 | |||
| FDA-2023-N-0002-0002 | FDA | None FDA-2023-N-0002 | FOI Summary oA 200-611 - Approved January 11, 2023 | Supporting & Related Material | Background Material | 2023-05-03T04:00:00Z | 2023 | 5 | 2023-05-04T19:54:16Z | 0 | 0 | 09000064859c2658 | |||
| FDA-2023-N-0002-0001 | FDA | None FDA-2023-N-0002 | New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications | Rule | Final Rule | 2023-05-03T04:00:00Z | 2023 | 5 | 2023-05-03T04:00:00Z | 2023-05-03T20:15:01Z | 2023-09212 | 0 | 0 | 09000064859c163d |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;